INFLUENZA THERAPEUTIC

Application 753/KOLNP/2005 published 2006-11-03, filed 2005-04-28
The present invention provides methods and compositions for inhibiting influenza infection and/or replication based on the phenomenon of RNA interference (RNAi) well as systems for identifying effective siRNAs and shRNAs for inhibiting influenza virus and systems for studying influenza virus infective mechanisms. The invention also provides methods and compositions for inhibiting infection, pathogenicity and/or replication of other infectious agents, particularly those that infect cells that are directly accessible from outside the body, e.g., skin cells or mucosal cells. In addition, the invention provides compositions comprising an RNAi-inducing entity, e.g., an siRNA, shRNA, or RNAi-inducing vector targeted to an influenza virus transcript and any of a variety of delivery agents. The invention further includes methods of use of the compositions for treatment of influenza. (FIG.11 a,b)

Applicant

MASSACHUSETTS INSTITUTE OF TECHNOLOGY.,
FIVE CAMBRIDGE CENTER, CAMBRIDGE, MA 02142-1493, USA.

Inventor

CHEN, JIANZHU EISEN, HERMAN N. GE, QING

International Info

Classification: A61KL
Publication Number: WO 04/028471
Application Date: 2003-09-29

Priority Information

60/414,457 US 2002-09-28
60/446,377 US 2003-02-10